Genevieve Roberts thought weight-loss drugs were a miracle – until excruciating side-effects sent her straight back to a ...

Someone is considered to be diabetic if the blood glucose/sugar levels are persistently above normal. People with diabetes usually have problems converting food nutrients into energy for their body ...

Treatment for diabetes depends partly on the type of diabetes a person has. People with type 1 diabetes will require insulin injections to ... epinephrine pen, they should use the device while ...

In this case, they’ll recommend a different medication for your diabetes. Injection site reactions with Mounjaro are usually mild and go away on their own. If you have an injection site reaction ...

Keep track of all the Rays' roster moves and injury updates here. This page will be updated throughout the offseason. Jan. 23: Acquired LHP Brandon Eisert from the Blue Jays for cash considerations ...

A 15-year-old boy is celebrating his progress online, posting two remarkably similar X-ray images of his legs, taken eight months apart. He claims a drug called Aromasin has kept his growth plates ...

In our January research highlights, we look at new research into how AI-powered screening could spot type 2 diabetes risk years in advance, and a new study into genetically altered beta cell therapy ...

a new weekly formulation of established GLP-1 diabetes drug with the added benefit of glucose reduction, better weight loss results and a new injection pen. AstraZeneca announced that the EC green ...

Weeping legs, which describes fluid that leaks or oozes from the leg, can be a complex condition to manage. While your legs may weep fluid for various reasons, it could be a symptom, or complication, ...

Mounjaro (tirzepatide) is a brand-name drug prescribed to treat type 2 diabetes in adults. Mounjaro comes as a solution inside injection pens that you’ll administer weekly as a subcutaneous ...

Moreover, the list of 15 is expected to include the blockbuster drug semaglutide, the GLP-1 class drug behind the brand-name weight-loss and diabetes drugs Wegovy and Ozempic, made by Novo Nordisk.